Oltipraz regulates different categories of genes relevant to chemoprevention in human hepatocytes

Amélie Piton1, Eric Le Ferrec, Sophie Langouët

  • 1INSERM U620, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes I, 35043 Rennes, France.

Carcinogenesis
|October 23, 2004
PubMed

Insights

Oltipraz (OPZ) alters human gene expression in detoxification, antioxidant, and cell cycle pathways. Individual responses vary, highlighting the need for human-specific chemoprevention research.

Area of Science:

  • Molecular Toxicology
  • Human Hepatocyte Biology
  • Chemoprevention Research

Background:

  • Chemical compounds can be cytotoxic or carcinogenic, necessitating preventative strategies.
  • Oltipraz (OPZ) is a promising chemoprotector, known to induce phase II enzymes for carcinogen detoxification.
  • Limited data exists on OPZ's impact on global gene expression in human cells.

Purpose of the Study:

  • To investigate the effects of oltipraz (OPZ) on global gene expression patterns in primary human hepatocytes.
  • To identify specific metabolic pathways and genes regulated by OPZ in humans.
  • To compare human cellular responses to OPZ with those observed in rodents.

Main Methods:

  • Utilized microarrays and reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
  • Analyzed mRNA expression patterns in primary human hepatocytes treated with OPZ.
  • Validated findings at both mRNA and protein levels.

Main Results:

  • OPZ significantly alters human gene expression across detoxification, antioxidant defense, xenobiotic transport, cell cycle, and stress response pathways.
  • Identified novel genes regulated by OPZ, some highly relevant to chemoprevention.
  • Observed inter-individual variability in OPZ response, suggesting personalized treatment efficacy.
  • Demonstrated species-specific differences in gene regulation by OPZ compared to rodent models.

Conclusions:

  • Oltipraz (OPZ) modulates a broad spectrum of genes in human hepatocytes, impacting key pathways relevant to chemoprevention.
  • Individual genetic variations influence cellular responses to OPZ, impacting potential therapeutic efficacy.
  • Human-specific studies are crucial for accurately predicting the effects of chemopreventive agents like OPZ due to species differences.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...